Meeting
2017 ASCO Annual Meeting
Evolution and clinical impact of genomic alterations detectable in circulating tumor DNA of 1150 advanced EGFR-mutant (mt) lung cancer patients.
Authors
Collin M. Blakely
Department of Medicine, University of California San Francisco, San Francisco, CA
Collin M. Blakely , Wei Wu , Matthew A. Gubens , Julia Rotow , Victoria Wang , Kimberly Banks , Richard B. Lanman , Philip C. Mack , Hatim Husain , Caroline Elizabeth McCoach , Robert Charles Doebele , Jonathan Riess , Trever Grant Bivona
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 35, 2017 (suppl; abstr 9009)
DOI
10.1200/JCO.2017.35.15_suppl.9009
Abstract #
9009
Poster Bd #
335
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Real-time circulating tumor DNA profiling of advanced cholangiocarcinoma (CCA).
First Author: Kabir Mody
Poster
2021 ASCO Annual Meeting
Whole-exome sequencing in advanced-stage sensitizing EGFR mutation non-small cell lung cancer: Explore resistance biomarkers to EGFR TKI treatment.
First Author: Chanida Vinayanuwattikun
Poster
2020 Genitourinary Cancers Symposium
Genomic landscape of circulating tumor (ct)-DNA alterations in patients with penile cancer.
First Author: Amin Nassar
Poster
2018 ASCO Annual Meeting
The nationwide cancer genome screening project in Japan SCRUM-Japan GI-SCREEN: Efficient identification of cancer genome alterations in advanced gastric cancer (GC).
First Author: Satoshi Yuki